Hutchison China Meditech Limited Holding(s) in Company (2713B)
29 Janvier 2020 - 8:25AM
UK Regulatory
TIDMHCM
RNS Number : 2713B
Hutchison China Meditech Limited
29 January 2020
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the Hutchison China MediTech Limited;
underlying issuer of existing shares Legal Entity Identifier: 2138006X34YDQ6OBYE79
to which voting rights are attached(ii)
:
-----------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer X
-----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
-----
An acquisition or disposal of financial instruments
-----
An event changing the breakdown of voting rights
-----
Other (please specify)(iii) : Notification threshold crossed following X
a change in voting rights arising from an offering of American depositary
shares by Hutchison China MediTech Limited
-----
3. Details of person subject to the notification obligation(iv)
Name Hutchison Healthcare Holdings Limited
City and country of registered office British Virgin Islands
(if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
Name
-----------------------------------------------------
City and country of registered office
(if applicable)
-----------------------------------------------------
5. Date on which the threshold was 27/01/2020
crossed or reached(vi) :
-----------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 29/01/2020
-----------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer(vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ----------------------- ------------------- ----------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 48.26% - 48.26% 688,906,450
------------------ ----------------------- ------------------- ----------------------
Position of
previous notification
(if
applicable) 49.86% - 49.86%
------------------ ----------------------- ------------------- ----------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-----------------------------
Ordinary Shares
(KYG4672N1198) 332,478,770 - 48.26% -
------------------------ ----------------------------- ------------------------- ---------------------
American - - - -
Depositary
Shares
(US44842L1035)
------------------------ ----------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 332,478,770 48.26%
------------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion Period(xi) rights that may rights
be acquired if
the instrument
is
exercised/converted.
----------- ----------------------------------- -------------------------------- ---------------------
SUBTOTAL 8. B 1
----------------------------------- -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date(x) Conversion cash voting rights rights
instrument Period (xi) settlement(xii)
----------------- ---------------------- ----------------------- --------------------
SUBTOTAL 8.B.2
----------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary)
Name(xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
CK Hutchison Holdings
Limited - indirect,
but ultimate, owner
of the shareholder 48.26% 48.26%
---------------------- --------------------- ------------------------
Hutchison Whampoa
(China) Limited
- direct owner of
the shareholder
and a subsidiary
of CK Hutchison
Holdings Limited 48.26% 48.26%
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights
held
The date until which the voting rights
will be held
11. Additional information(xvi)
Notification threshold crossed following a change in voting rights arising
from an offering of American
depositary shares by Hutchison China MediTech Limited.
Place of completion Hong Kong
Date of completion 29 January 2020
----------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLUKABRRWUAURR
(END) Dow Jones Newswires
January 29, 2020 02:25 ET (07:25 GMT)
Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
